Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



Johnson & Johnson to Buy Aragon Pharmaceuticals for $650 Million Up Front

The board of privately held Aragon Pharmaeuticals, a firm that concentrates on the development of hormonally based cancer treatments, has agreed to be acquired by Johnson & Johnson (NYSE: JNJ  ) for an upfront cash payment of $650 million, Johnson & Johnson and Aragon Pharma announced today.

If certain milestones are met, Johnson & Johnson will make additional payments up to $350 million to Aragon Pharma. The acquisition of Aragon Pharma includes its androgen receptor antagonist program targeting the treatment of prostate cancer, including its primary product candidate in phase 2 development, ARN-509. Prior to Johnson & Johnson's assuming ownership of Aragon and its androgen receptor antagonist treatments, Aragon Pharma will spin off all its other assets into a separate entity called Seragon Pharmaceuticals. Johnson & Johnson will have no ownership stake in Seragon Pharma, nor hold any rights to its products or technologies, Aragon said.

Dr. Peter Lebowitz, global therapeutic area head, oncology, for Janssen Research & Development (a Johnson & Johnson company), was quoted as saying, "The acquisition of Aragon further enhances our leadership in prostate cancer drug development. ARN-509 complements Zytiga and provides the potential for exciting, novel approaches to treat prostate cancer patients."

The transaction is expected to close in the third quarter of 2013, and is subject to regulatory and closing conditions including antitrust clearance.


Read/Post Comments (0) | Recommend This Article (2)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2493483, ~/Articles/ArticleHandler.aspx, 9/25/2016 1:54:15 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 1 day ago Sponsored by:
DOW 18,261.45 -131.01 -0.71%
S&P 500 2,164.69 -12.49 -0.57%
NASD 5,305.75 -33.78 -0.63%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/23/2016 4:00 PM
JNJ $118.81 Down -0.65 -0.54%
Johnson and Johnso… CAPS Rating: *****